Lonicera caerulea eye-protecting oral liquid as well as preparation method and application thereof

Through the combined use of blue indigo extract with traditional Chinese medicine composition and other ingredients, an efficient oral liquid for eye protection was prepared, which solved the problems of poor treatment effect and low stability of visual fatigue and macular lesions in the prior art, and achieved Significant improvement in efficacy and stability.

CN118903258APending Publication Date: 2024-11-08HEILONGJIANG RENHETANG PHARM CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202410630628.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-05-21
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing oral fluids are poor in the treatment of visual fatigue and macular lesions and are not stable, and cannot meet clinical needs.

Method used

Using Chinese herbal compositions such as blue indigo fruit extract, cassia, forsythia, knotweed, bupleurum, roasted licorice, etc., combined with lutein, taurine, propylene glycol and hydroxypropyl methylcellulose, extracted and decocted by ultrasonic Cooking method to prepare eye protection oral liquid, adjust pH value to improve stability and efficacy.

Benefits of technology

This eye-protective oral liquid promotes metabolism by unblocking the eye meridians and accelerating blood circulation, significantly alleviating visual fatigue and macular lesions, improving treatment effect and stability, and without adverse reactions.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention provides a lonicera caerulea eye-protecting oral liquid as well as a preparation method and application thereof, and belongs to the technical field of oral liquid preparations. The method comprises the following steps: mixing lonicera caerulea and an ethanol solution, carrying out ultrasonic extraction, evaporating, adding water, and redissolving to obtain a lonicera caerulea extracting solution; the eye-protecting traditional Chinese medicine composition is prepared by mixing and decocting concha haliotidis, fructus forsythiae, rhizoma polygoni cuspidati, wine-processed radix bupleuri, honey-fried licorice root and water for 1-3 times, and combining decoction liquid. The lonicera caerulea extracting solution, the eye-protecting traditional Chinese medicine composition, the xanthophyll, the taurine, the propylene glycol and the hydroxypropyl methyl cellulose are mixed and stirred and then mixed with water, the pH of the solution is adjusted, and the eye-protecting oral liquid is obtained. According to the oral liquid disclosed by the invention, various active ingredients such as procyanidins, anthocyanin, anthocyanin and flavonoids in the lonicera caerulea extracting solution, the lutein and the taurine are combined with various traditional Chinese medicine ingredients for common use, so that the oral liquid has the effects of dredging eye meridians, accelerating periorbital blood circulation, promoting eye metabolism and relieving eye fatigue; the maculopathy can be effectively treated and relieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of oral liquid preparations, and in particular relates to an oral liquid for protecting eyes made from blue loquat fruit, and a preparation method and application thereof. Background Art

[0002] With the popularization of electronic devices and the accelerated pace of modern life and work, the number of people suffering from visual fatigue is increasing. The specific manifestations are dry and sore eyes, intermittent blurred vision, macular degeneration, decreased vision, etc. In severe cases, it may even cause nausea, dizziness, headache and other symptoms, which directly affect people's work and life.

[0003] Blue indigo fruit is a deciduous shrub of the genus Lonicera in the family Caprifoliaceae. According to the "Changbai Mountain Plant Medicinal Records", blue indigo fruit tastes bitter and is cool in nature. It can clear away heat and fire, disperse carbuncle and reduce swelling, and treat heat and toxic sores such as breast carbuncle, intestinal carbuncle, erysipelas, etc. The fruit of blue indigo fruit is a juicy fleshy berry, which is rich in polyphenols, organic acids, sugars, minerals, vitamins and various trace elements. It has the effects of lowering blood pressure, improving myocardial ischemia, improving children's vision, and preventing skin aging.

[0004] The existing oral liquid for relieving visual fatigue has poor therapeutic effect due to unreasonable selection of ingredients, and is not stable and has a short storage time. Therefore, it is necessary to provide an eye protection oral liquid with good therapeutic effect and high stability to meet the deficiencies of the existing technology. Summary of the invention

[0005] In view of this, the object of the present invention is to provide a blue indigo fruit eye protection oral liquid and a preparation method and application thereof, so as to solve the problems of poor therapeutic effect and low stability of existing oral liquids.

[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0007] The present invention provides an eye-protecting Chinese medicine composition, comprising the following raw materials in parts by weight:

[0008] 16-24 parts of Semen Cassiae, 12-16 parts of Fructus Forsythiae, 6-12 parts of Polygonum Cuspidati, 4-8 parts of Radix Bupleuri, and 1-3 parts of Radix Glycyrrhizae Preparata.

[0009] The present invention also provides a method for preparing the eye-protecting Chinese medicine composition, comprising the following steps:

[0010] Mix Cassiae Cassiae, Fructus Forsythiae, Polygonum Cuspidati, Radix Bupleuri, and Radix Glycyrrhizae to obtain a material to be decocted, mix the material to be decocted with water, and decoct for 1 to 3 times, and combine the decoctions to obtain the eye-protecting Chinese medicine composition.

[0011] Preferably, the mass ratio of the material to be boiled and water is 1:4-6; and the boiling time for each time is 30-60 minutes.

[0012] The present invention also provides an eye-protecting oral liquid containing the eye-protecting Chinese medicine composition or the eye-protecting Chinese medicine composition prepared by the preparation method, comprising the following raw materials in percentage by mass:

[0013] 20-30% of blue lonicera caerulea extract, 10-15% of eye protection Chinese medicine composition, 4-7% of lutein, 5-8% of taurine, 1-2% of propylene glycol, 0.5-0.8% of hydroxypropyl methylcellulose and the balance of water.

[0014] The present invention also provides a method for preparing the eye protection oral liquid, comprising the following steps:

[0015] 1) extracting the mixture of blue honeysuckle and ethanol solution by ultrasonic method, evaporating the mixture and re-dissolving it in water to obtain blue honeysuckle extract;

[0016] 2) Mixing the blue loquat extract, the eye protection Chinese medicine composition, lutein, taurine, propylene glycol and hydroxypropyl methylcellulose, stirring, mixing with water, adjusting the pH of the solution, and obtaining the eye protection oral solution.

[0017] Preferably, the ethanol has a volume fraction of 40 to 60%; and the mass volume ratio of the blue lonicera fruit to the ethanol solution is 1 g: 30 to 40 mL.

[0018] Preferably, the frequency of the ultrasonic extraction is 550-650W, the time of the ultrasonic extraction is 60-80min, and the temperature of the ultrasonic extraction is 30-40°C.

[0019] Preferably, water is added for redissolution after evaporation, and the mass ratio of the remaining solid to water is controlled to be 1:7-15.

[0020] Preferably, in step 2), the pH is adjusted to 6.5-7.5.

[0021] The present invention also provides the use of the eye-protecting Chinese medicine composition or the eye-protecting oral liquid in the preparation of medicines for relieving visual fatigue, preventing and treating dry eyes and macular degeneration.

[0022] Compared with the prior art, the present invention has the following beneficial effects:

[0023] The oral liquid of the present invention uses various active ingredients such as proanthocyanidins, anthocyanidins, anthocyanins, flavonoids, lutein and taurine in the blue honeysuckle extract together with various traditional Chinese medicine ingredients, has the effects of dredging eye meridians, accelerating blood circulation around the eyes, promoting eye metabolism, and relieving eye fatigue, and can effectively treat and relieve macular degeneration.

[0024] The oral liquid of the present invention uses Semen Cassiae as the main drug which has the functions of nourishing the kidney and clearing the liver, invigorating qi and nourishing blood; uses Fructus Forsythiae which has the functions of clearing away heat and detoxifying, dispersing wind and dissipating heat as the assistant drug; uses Polygonum cuspidatum which has the functions of regulating qi and dispersing blood stasis and Radix Bupleuri which has the functions of dispersing liver and relieving depression as the adjuvant drug; and uses Radix Glycyrrhizae Preparata as the guiding drug. All the drugs are used together to achieve the effects of nourishing the liver and kidney, dispersing wind and clearing heat, and clearing the liver and improving eyesight.

[0025] The present invention uses propylene glycol and hydroxypropyl methylcellulose as stabilizers and adjusts the appropriate pH of the solution, which can reduce the deterioration and decomposition of each effective ingredient and greatly improve the stability, absorption effect and taste suitability of the oral solution. DETAILED DESCRIPTION

[0026] The present invention provides an eye-protecting Chinese medicine composition, comprising the following raw materials in parts by weight:

[0027] 16-24 parts of Semen Cassiae, 12-16 parts of Fructus Forsythiae, 6-12 parts of Polygonum Cuspidati, 4-8 parts of Radix Bupleuri, and 1-3 parts of Radix Glycyrrhizae Preparata.

[0028] In the present invention, the dosage of Semen Cassiae is preferably 18 to 22 parts; Semen Cassiae is salty and cold in nature, enters the liver meridian and kidney meridian, and has the effects of calming the liver and suppressing yang, removing heat, and improving eyesight.

[0029] The dosage of the forsythia is preferably 13 to 15 parts; the forsythia is bitter in nature and slightly cold, and enters the lung meridian, heart meridian, and small intestine meridian. It has the effects of clearing away heat, detoxifying, dispersing knots, and reducing swelling.

[0030] The dosage of the Polygonum cuspidatum is preferably 7 to 11 parts; Polygonum cuspidatum is bitter, sour, slightly cold in nature, enters the liver meridian and gallbladder meridian, and has the effects of dispelling wind, promoting dampness, removing blood stasis, and promoting menstruation.

[0031] The amount of the wine bupleurum is 5 to 7 parts; the preparation method of the wine bupleurum is: take bupleurum slices and mix them with yellow wine, steam until they are thoroughly moistened, put them in a pot, heat them with a slow fire, stir-fry them until they are dry, take them out and let them cool. For every 100kg of bupleurum slices, 10kg of yellow wine is used. The wine bupleurum has the effects of soothing the liver and relieving depression, clearing away heat and detoxifying, and dispelling wind and cold.

[0032] The dosage of the licorice root is preferably 2 parts; the licorice root is sweet and flat in nature. It enters the spleen meridian, stomach meridian, and lung meridian. It has the effects of harmonizing the middle and relieving urgency, moistening the lungs, detoxifying, and harmonizing various medicines.

[0033] The present invention also provides a method for preparing the eye-protecting Chinese medicine composition, comprising the following steps:

[0034] Mix Cassiae Cassiae, Fructus Forsythiae, Polygonum Cuspidati, Radix Bupleuri, and Radix Glycyrrhizae to obtain a material to be decocted, mix the material to be decocted with water, and decoct for 1 to 3 times, and combine the decoctions to obtain the eye-protecting Chinese medicine composition.

[0035] In the present invention, the mass ratio of the material to be boiled and water is preferably 1:4-6, more preferably 1:4.5-5.5; the time for each boiling is preferably 30-60 minutes, more preferably 35-55 minutes.

[0036] The present invention also provides an eye-protecting oral liquid containing the eye-protecting Chinese medicine composition or the eye-protecting Chinese medicine composition prepared by the preparation method, comprising the following raw materials in percentage by mass:

[0037] 20-30% of blue lonicera caerulea extract, 10-15% of eye protection Chinese medicine composition, 4-7% of lutein, 5-8% of taurine, 1-2% of propylene glycol, 0.5-0.8% of hydroxypropyl methylcellulose and the balance of water.

[0038] In the present invention, the dosage of the blue honeysuckle extract is preferably 22-28%; the blue honeysuckle extract contains a variety of active ingredients such as proanthocyanidins, anthocyanidins, anthocyanins, flavonoids, etc. The proanthocyanidins have the effects of enhancing vision, eliminating eye fatigue, resisting radiation, promoting the regeneration of rhodopsin in retinal cells, preventing myopia, and improving vision; proanthocyanidins can also protect eye blood vessels, promote eye blood circulation, improve the ability of oxygen and blood to be transmitted to the eye, and effectively prevent and treat eye diseases, including the formation of cataracts and macular degeneration.

[0039] Anthocyanins can promote the synthesis of rhodopsin in the retina, promote blood circulation in the eyes, relieve stiffness of the ciliary muscles, maintain normal intraocular pressure, relieve eye fatigue, and help prevent the occurrence of myopia, dry eyes, cataracts and other eye diseases. Anthocyanins have a strong antioxidant effect, which can remove free radicals in the eyes, prevent eye diseases, eye pain, photophobia, blurred vision, dry eyes and other symptoms, and have a good effect on relieving symptoms of eye fatigue, thereby improving the health of the eyes. Flavonoids can help reduce oxidative stress in the eyes, protect the retina from free radical damage, and maintain eye health.

[0040] The dosage of the eye protection Chinese medicine composition is preferably 11-14%;

[0041] The dosage of lutein is preferably 5-6%. Lutein is a carotenoid and is the only vitamin that selectively exists in the macula region of the retina. Ultraviolet rays can generally be filtered out by the cornea and lens, while blue light can penetrate the eyeball directly to the retina and macula. Lutein can absorb blue light that is harmful to the retina, and has the effect of preventing changes in the physiological structure and function of the eye and resolving light damage to the eye.

[0042] The dosage of taurine is preferably 6-7%; taurine is an important essential amino acid for the human body and has a wide range of physiological functions. After supplementing taurine, the SOD activity in the lens is significantly increased, the MDA content is significantly reduced, the degree of lens opacity is significantly improved, and it has a significant inhibitory effect on retinal light damage and photoreceptor cell apoptosis, and has the functions of nourishing the optic nerve, improving visual fatigue, and improving vision.

[0043] The usage amount of the propylene glycol is preferably 1.2-1.8%; the usage amount of the hydroxypropyl methylcellulose is preferably 0.6-0.7%.

[0044] The present invention also provides a method for preparing the oral eye protection liquid, comprising the following steps:

[0045] 1) extracting the mixture of blue honeysuckle and ethanol solution by ultrasonic method, evaporating the mixture and re-dissolving it in water to obtain blue honeysuckle extract;

[0046] 2) Mixing the blue loquat extract, the eye protection Chinese medicine composition, lutein, taurine, propylene glycol and hydroxypropyl methylcellulose, stirring, mixing with water, adjusting the pH of the solution, and obtaining the eye protection oral solution.

[0047] In the present invention, blue honeysuckle and ethanol solution are mixed and ultrasonically extracted, and water is added to dissolve after evaporation to obtain blue honeysuckle extract. The ethanol is preferably ethanol with a volume fraction of 40 to 60%, and more preferably ethanol with a volume fraction of 45 to 55%; the mass volume ratio of blue honeysuckle and ethanol solution is preferably 1g:30 to 40mL, and more preferably 1g:32 to 38mL; the frequency of the ultrasonic extraction is preferably 550 to 650W, and more preferably 580 to 630W; the time of the ultrasonic extraction is preferably 60 to 80min, and more preferably 65 to 75min; the temperature of the ultrasonic extraction is preferably 30 to 40°C, and more preferably 32 to 38°C; after evaporation, water is added to dissolve, and the mass ratio of the remaining solid to water is preferably 1:7 to 15, and more preferably 1:8 to 14.

[0048] In the present invention, the blue loquat extract, the eye protection Chinese medicine composition, lutein, taurine, propylene glycol and hydroxypropyl methylcellulose are mixed and stirred, and water is added to the total amount to adjust the pH of the solution to obtain the eye protection oral solution. The pH is adjusted to 6.5-7.5, and further adjusted to 6.8-7.2.

[0049] The present invention also provides the use of the eye-protecting Chinese medicine composition or the eye-protecting oral liquid in the preparation of medicines for relieving visual fatigue, preventing and treating dry eyes and macular degeneration.

[0050] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0051] Example 1

[0052] 20 g of blue honeysuckle and 700 mL of 50% ethanol solution were mixed, and extracted under ultrasonic conditions of 600 W and 35° C. for 70 min. After evaporation, water was added to dissolve the mixture, and the mass ratio of the remaining solid to water was controlled to be 1:10 to obtain a blue honeysuckle extract.

[0053] Take 20g of Semen Cassiae, 14g of Forsythia, 10g of Polygonum cuspidatum, 6g of Radix Bupleuri, and 2g of Radix Glycyrrhizae Preparata, add 260mL of water, soak for 2h, then boil over high heat, turn to low heat and boil for 45min, filter, and take the filtrate to obtain the first filtrate; add 260mL of water to the filter residue, boil for 45min, filter, and take the filtrate to obtain the second filtrate. Combine the first filtrate and the second filtrate to obtain the eye protection Chinese medicine composition.

[0054] 25% of blue lonicera extract, 13% of eye protection Chinese medicine composition, 6% of lutein, 7% of taurine, 1.5% of propylene glycol and 0.6% of hydroxypropyl methylcellulose are mixed and stirred, then mixed with water and the pH of the solution is adjusted to 7.2 to obtain the eye protection oral liquid.

[0055] Example 2

[0056] 20 g of blue honeysuckle and 600 mL of 40% ethanol solution were mixed, and extracted under ultrasonic conditions of 550 W and 30° C. for 60 min. After evaporation, water was added to dissolve the mixture, and the mass ratio of the remaining solid to water was controlled to be 1:7 to obtain a blue honeysuckle extract.

[0057] Take 16g of Semen Cassiae, 12g of Forsythia, 6g of Polygonum cuspidatum, 4g of Radix Bupleuri, and 1g of Radix Glycyrrhizae Preparata, add 156mL of water, soak for 2h, then boil over high heat, turn to low heat and boil for 30min, filter, and take the filtrate to obtain the first filtrate; add 156mL of water to the filter residue, boil for 30min, filter, and take the filtrate to obtain the second filtrate. Combine the first filtrate and the second filtrate to obtain the eye protection Chinese medicine composition.

[0058] 20% of blue lonicera extract, 10% of eye protection Chinese medicine composition, 4% of lutein, 5% of taurine, 1% of propylene glycol and 0.5% of hydroxypropyl methylcellulose are mixed and stirred, then mixed with water and the pH of the solution is adjusted to 6.5 to obtain the eye protection oral liquid.

[0059] Example 3

[0060] 20 g of blue honeysuckle and 800 mL of 60% ethanol solution were mixed, and extracted under ultrasonic conditions of 650 W and 40° C. for 80 min. After evaporation, water was added to dissolve the mixture, and the mass ratio of the remaining solid to water was controlled to be 1:15 to obtain a blue honeysuckle extract.

[0061] Take 24g of Semen Cassiae, 16g of Forsythia, 12g of Polygonum cuspidatum, 8g of Radix Bupleuri, and 3g of Radix Glycyrrhizae Preparata, add 378mL of water, soak for 2h, then boil over high heat, turn to low heat and boil for 60min, filter, and take the filtrate to obtain the first filtrate; add 378mL of water to the filter residue, boil for 60min, filter, and take the filtrate to obtain the second filtrate. Combine the first filtrate and the second filtrate to obtain the eye protection Chinese medicine composition.

[0062] 30% of blue lonicera extract, 15% of eye protection Chinese medicine composition, 7% of lutein, 8% of taurine, 2% of propylene glycol and 0.8% of hydroxypropyl methylcellulose are mixed and stirred, then mixed with water and the pH of the solution is adjusted to 7.5 to obtain the eye protection oral liquid.

[0063] Test Example 1

[0064] Effect of eye protection oral solution on macular degeneration in rats

[0065] Thirty adult male brown Norwegian rats, weighing 200-300 g, were examined by slit lamp microscopy and fundus examination to exclude rats with abnormal refractive media and fundus. The rats were randomly divided into model group, Example 1 group, Example 2 group, and Example 3 group, with 6 rats in each group. The rats were anesthetized by intraperitoneal injection of ketamine (5 mL / kg), and 0.5% tropicamide solution was dropped in both eyes. The rats were placed in front of a semiconductor laser machine, and krypton laser (647 nm) was used to photocoagulate 10 points of the retina equidistant around the optic disc 1-2 PD outside the optic disc. 14 days after fundus photocoagulation, the rats in each group were anesthetized, and 10% fluorescein sodium (2.5 mL / kg) was injected into the left lower peritoneum for fluorescein fundus angiography. The model group was gavaged with 2 mL of normal saline every day, and the Example 1 group, Example 2 group, and Example 3 group were gavaged with 1.8 mL / kg of eye protection oral solution.

[0066] Detection method: After 30 days of administration, the rats were anesthetized and killed, and the eyeballs were immediately removed. After being placed in a 10% formaldehyde solution at room temperature overnight, the eyeballs were embedded in paraffin, sliced, and stained to prepare light microscopic specimens. The CNV was selected under the 100x field of view of the light microscope, and the maximum central thickness (the distance from the pigment epithelium to the highest point of the CNV in the retina) and area (including vascular smooth muscle cells, poorly differentiated myofibroblasts, inflammatory cells, and proliferating retinal pigment epithelial cells) of the CNV in the continuous sections were measured using an image analyzer.

[0067] Experimental results: The tissue sections were observed and the CNV thickness and area of ​​each group of rats were measured. The results are shown in Table 1.

[0068] Table 1 Measurement results of CNV thickness and area of ​​rats in each group

[0069] Group CNV maximum central thickness (μm) <![CDATA[CNV occurrence area (mm 2 )]]> Model Group 2.9354±0.415 18.519±4.147 Example 1 Group 1.831±0.168 10.174±2.059 Example 2 Group 2.036±0.341 12.345±2.316 Example 3 Group 2.109±0.143 13.704±2.213

[0070] It can be seen from Table 3 that, compared with the model group, the eye protection oral liquids prepared in Examples 1 to 3 can effectively reduce the proliferation of fibrovascular tissue, reduce tissue damage, alleviate tissue edema, and reduce the area and thickness of CNV. The effect of Example 1 group is the most obvious, indicating that the eye protection oral liquid prepared by the present invention has a certain inhibitory effect on the formation and growth of CNV, and has good prospects in the clinical treatment of macular degeneration.

[0071] Test Example 2

[0072] Effect of eye protection oral solution on visual fatigue induced by light in rats

[0073] Clean-grade SD rats (male) weighing 300±20g were taken and adaptively fed for 7 days with normal water and food. They were randomly divided into 6 groups according to their body weight, namely normal control group, model control group, positive control group, Example 1 group, Example 2 group and Example 3 group, with 10 rats in each group. The normal control group was gavaged with distilled water for 3 days; the model control group was gavaged with normal water and food without drug treatment; the positive control group was gavaged with 1.8mL / kg of Qiju Dihuang oral liquid for 3 days; Example 1 group, Example 2 group and Example 3 group were gavaged with 1.8mL / kg of eye protection oral liquid for 3 days.

[0074] Establishment of illumination model: The normal group was not illuminated; the model group was illuminated on the 3rd day, and the positive control group and Example 1, Example 2 and Example 3 groups were illuminated after the last administration. The light source was a 100W incandescent lamp at a vertical height of 30cm from the rats, and the illumination time was 15min. After the illumination of each group, the state of the rat eyeballs was observed under a slit lamp, and photographed and recorded.

[0075] Observation indicators and detection methods

[0076] Pupil diameter / eyelid opening value: The pupil diameter and eyelid opening value of rats were measured, and the ratio of the two, i.e., pupil diameter / eyelid opening value, was calculated.

[0077] Experimental results: as shown in Table 2.

[0078] Table 2 Ratio of pupil diameter to eyelid opening value in rats

[0079] Group Pupil / eyelid Normal group 0.1907±0.0632 Model Group 0.2816±0.0314 Positive Control 0.2211±0.0193 Example 1 0.1791±0.0267 Example 2 0.1887±0.0184 Example 3 0.1998±0.0291

[0080] As shown in Table 2, compared with the normal group, the pupil diameter / eyelid opening value of the model group rats was significantly increased; compared with the model group, the pupil diameter / eyelid opening value of the positive control group and Example 1, Example 2 and Example 3 rats was significantly reduced. This shows that the Qiju Dihuang oral liquid and the eye protection oral liquid of the present invention both have a significant effect on reducing the pupil diameter / eyelid opening value of rats, and the effect of the eye protection oral liquid of the present invention is significantly better than that of the positive control group.

[0081] Test Example 3

[0082] 180 patients with visual fatigue were selected, including 85 men and 95 women, and randomly divided into three groups, with an age of 7 to 25 years old. The clinical symptoms included intolerance to long-term vision, temporary blurred vision, squinting, visual fatigue, dry eyes, burning sensation, tearing, sore and itchy eyes, dizziness and headache, pale complexion, palpitations and fatigue, pale tongue and weak pulse, soreness of waist and knees, insomnia and dreaminess, and forgetfulness. The eye protection oral liquid of the present invention was used for treatment, 10 mL each time, 3 times a day, and taken for 4 weeks, and the scores were calculated according to the standards of no (0 point), slightly (1 point), more obvious (2 points), and very obvious (3 points).

[0083] According to the "Standards for Diagnosis and Efficacy of Chinese Medicine Diseases and Syndromes" (Standard Registration No. 94-0080), efficacy index = [(symptom score before treatment - symptom score after treatment) / symptom score before treatment] × 100%.

[0084] Cure: efficacy index ≥90%.

[0085] Markedly effective: the efficacy index is 60% to 89%.

[0086] Effective: The efficacy index is 30% to 59%.

[0087] Ineffective: efficacy index <30%.

[0088] Total effective rate = cure rate + marked effective rate + effective rate.

[0089] Experimental results: as shown in Table 3.

[0090] Table 3 Effect of the eye protection oral solution of the present invention on improving clinical symptoms of visual fatigue

[0091] Group cure Significant effect efficient invalid Example 1 57 1 2 0 Example 2 56 1 2 1 Example 3 55 2 1 2

[0092] As shown in Table 3, after using the eye protection oral liquid of Example 1 of the present invention, 57 of 60 patients were cured, 1 was markedly effective, 2 were effective, and 0 was ineffective, with a total effective rate of 100% and a cure rate of 95%; after using the eye protection oral liquid of Example 2 of the present invention, 56 of 60 patients were cured, 1 was markedly effective, 2 were effective, and 1 was ineffective, with a total effective rate of 98.33% and a cure rate of 93.33%; after using the eye protection oral liquid of Example 3 of the present invention, 55 of 60 patients were cured, 2 were markedly effective, 1 was effective, and 2 were ineffective, with a total effective rate of 96.66% and a cure rate of 91.66%. During the trial period, no adverse reactions occurred in the patients.

[0093] It can be seen from the above embodiments and test examples that the eye protection oral liquid of the present invention can relieve eye fatigue and effectively treat and relieve macular degeneration.

[0094] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A Chinese medicine composition for eye protection, characterized in that: The invention comprises the following raw materials in parts by weight: 16-24 parts of Semen Cassiae, 12-16 parts of Fructus Forsythiae, 6-12 parts of Polygonum Cuspidati, 4-8 parts of Radix Bupleuri, and 1-3 parts of Radix Glycyrrhizae Preparata.

2. The method for preparing the eye-protecting Chinese medicine composition according to claim 1, characterized in that: The following steps are involved: Mix Cassiae Cassiae, Fructus Forsythiae, Polygonum Cuspidati, Radix Bupleuri, and Radix Glycyrrhizae to obtain a material to be decocted, mix the material to be decocted with water, and decoct for 1 to 3 times, and combine the decoctions to obtain the eye-protecting Chinese medicine composition.

3. The preparation method according to claim 2, characterized in that: The mass ratio of the material to be boiled and water is 1:4-6; the boiling time for each time is 30-60 minutes.

4. An eye-protecting oral liquid containing the eye-protecting Chinese medicine composition according to claim 1 or the eye-protecting Chinese medicine composition prepared by the preparation method according to claim 2 or 3, characterized in that: The following raw materials are included in mass percentage: 20-30% of blue lonicera caerulea extract, 10-15% of eye protection Chinese medicine composition, 4-7% of lutein, 5-8% of taurine, 1-2% of propylene glycol, 0.5-0.8% of hydroxypropyl methylcellulose and the balance of water.

5. The method for preparing the eye protection oral liquid according to claim 4, characterized in that: The following steps are involved: 1) extracting the mixture of blue honeysuckle and ethanol solution by ultrasonic method, evaporating the mixture and re-dissolving it in water to obtain blue honeysuckle extract; 2) Mixing the blue loquat extract, the eye protection Chinese medicine composition, lutein, taurine, propylene glycol and hydroxypropyl methylcellulose, stirring, mixing with water, adjusting the pH of the solution, and obtaining the eye protection oral solution.

6. The preparation method according to claim 5, characterized in that: The ethanol has a volume fraction of 40-60%; the mass volume ratio of the blue honeysuckle and the ethanol solution is 1g:30-40mL.

7. The preparation method according to claim 5, characterized in that: The frequency of the ultrasonic extraction is 550-650W, the time of the ultrasonic extraction is 60-80min, and the temperature of the ultrasonic extraction is 30-40°C.

8. The preparation method according to claim 5, characterized in that: After the evaporation, water is added for redissolution, and the mass ratio of the remaining solid to water is controlled to be 1:7-15.

9. The preparation method according to claim 5, characterized in that: Step 2) The pH is adjusted to 6.5-7.

5.

10. Use of the eye-protecting Chinese medicine composition according to claim 1, or the eye-protecting Chinese medicine composition prepared by the preparation method according to claim 2 or 3, or the eye-protecting oral liquid according to claim 4, or the eye-protecting oral liquid prepared by the preparation method according to any one of claims 5 to 9 in the preparation of drugs for relieving visual fatigue, preventing and treating dry eyes and macular degeneration.

Citation Information

Patent Citations

  • Lonicera caerulea lutein preparation, eye drops and application thereof in relieving eyestrain

    CN115364077A